The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2020
Filed:
Apr. 25, 2018
Applicant:
Glaxosmithkline Biologicals, SA, Rixensart, BE;
Inventor:
Paolo Costantino, Siena, IT;
Assignee:
GLAXOSMITHKLINE BIOLOGICALS SA, Rixensart, BE;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/095 (2006.01); A61K 9/00 (2006.01); C07K 14/22 (2006.01); A61K 39/08 (2006.01); A61K 39/116 (2006.01); A61K 39/05 (2006.01); A61K 39/385 (2006.01); A61K 39/00 (2006.01); A61K 39/102 (2006.01); A61K 39/09 (2006.01); A61K 39/29 (2006.01); A61K 39/02 (2006.01); A61K 39/12 (2006.01);
U.S. Cl.
CPC ...
A61K 39/095 (2013.01); A61K 9/0019 (2013.01); C07K 14/22 (2013.01); A61K 39/0017 (2013.01); A61K 39/0018 (2013.01); A61K 39/05 (2013.01); A61K 39/08 (2013.01); A61K 39/092 (2013.01); A61K 39/099 (2013.01); A61K 39/102 (2013.01); A61K 39/116 (2013.01); A61K 39/12 (2013.01); A61K 39/292 (2013.01); A61K 39/385 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55505 (2013.01); A61K 2039/575 (2013.01); A61K 2039/6037 (2013.01); A61K 2039/62 (2013.01); A61K 2039/627 (2013.01); A61K 2039/70 (2013.01);
Abstract
An injectable immunogenic composition comprising capsular saccharides from at least two of serogroups A, C, W135 and Y of, wherein said capsular saccharides are conjugated to carrier protein(s) and/or are oligosaccharides, and wherein (i) the composition comprises <50 μg meningococcal saccharide per dose, and/or (ii) the composition further comprises an antigen from one or more of: (a) serogroup B; (b)type B; and/or (c). Saccharide antigens in the compositions are generally conjugated to a carrier.